3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
2
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Nasopharyngeal Carcinoma
20
Squamous Cell Carcinoma of Head and Neck
7
Oropharyngeal Neoplasms
7
Prostatic Neoplasms
5
Carcinoma
4
Rectal Neoplasms
3
Nasopharyngeal Neoplasms
3
Mouth Neoplasms
3
Laryngeal Neoplasms
3
Hypopharyngeal Neoplasms
3
Head and Neck Neoplasms
3
Carcinoma, Squamous Cell
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Stomatitis
2
Pancreatic Adenocarcinoma
2
Neoplasm Metastasis
2
Meningeal Carcinomatosis
2
Lung Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Endometrial Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Neoplasms
1
Urinary Bladder Neoplasms
1
Tumor Virus Infections
1
Thyroid Carcinoma, Anaplastic
1
Stomatognathic Diseases
1
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
1
Sarcoma
1
Recurrence
1
Interventions
Cyclophosphamide
21
venetoclax
18
pembrolizumab
16
Dexamethasone
16
fludarabine
14
Cytarabine
13
Gemcitabine
9
pomalidomide
8
Rituximab
8
Carboplatin
8
Azacitidine
8
glofitamab
7
fludarabine phosphate
7
Lenalidomide
7
Immunotherapy, Adoptive
7
selinexor
6
Paclitaxel
6
Injections
6
Granulocyte Colony-Stimulating Factor
6
Cisplatin
6
daratumumab
5
Temozolomide
5
Oxaliplatin
5
Bevacizumab
5
zanubrutinib
4
ruxolitinib
4
Surgical Procedures, Operative
4
Nivolumab
4
Drug Therapy
4
Decitabine
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Recurrence
×
Radiotherapy, Intensity-Modulated
×
Clear all
NCT07423078
2026-04-13
WOLF
University of Pittsburgh
Phase 2
Recruiting
87 enrolled